Tetrodotoxin-resistant voltage-gated sodium channel (TTX-R Nav)

Tetrodotoxin-resistant (TTX-R) voltage-gated sodium channels, specifically the Nav1.5, Nav1.8, and Nav1.9 subtypes, are critical mediators of electrical excitability in the heart and peripheral nervous system [1][2]. Nav1.8 and Nav1.9 are predominantly expressed in nociceptive dorsal root ganglion (DRG) neurons, where they play a specialized role in the initiation and maintenance of pain signals, making them high-value targets for non-opioid analgesics [4]. Nav1.5 is the primary sodium channel in the myocardium, responsible for the rapid upstroke of the cardiac action potential and the maintenance of normal heart rhythm [5]. These channels are distinguished from tetrodotoxin-sensitive (TTX-S) isoforms, such as the brain-expressed Nav1.2, by specific structural motifs in the pore-forming region that significantly reduce their affinity for the toxin tetrodotoxin [3]. Pharmacological targeting of this TTX-R profile is often intended to treat chronic pain or arrhythmias while minimizing central nervous system side effects associated with inhibiting brain sodium channels [6]. However, achieving high selectivity for the nociceptive subtypes (Nav1.8/1.9) over the cardiac subtype (Nav1.5) is a major therapeutic challenge to ensure cardiovascular safety in pain management applications [5][6].

Other names

Nav1.5Nav1.8Nav1.9SCN5ASCN10ASCN11APeripheral tetrodotoxin-resistant sodium channelsCardiac sodium channel

Inhibition of sodium ion influx by binding to the alpha-subunit pore (typically at the local anesthetic receptor site), which stabilizes the inactivated state of the channel and reduces the frequency of action potential firing in excitable tissues [5][6].